{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:06:43Z","timestamp":1774969603217,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,6]]},"DOI":"10.1093\/cid\/cix739","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T23:13:15Z","timestamp":1502493195000},"page":"244-253","source":"Crossref","is-referenced-by-count":21,"title":["Trends in Invasive Pneumococcal Disease in Cancer Patients After the Introduction of 7-valent Pneumococcal Conjugate Vaccine: A 20-year Longitudinal Study at a Major Urban Cancer Center"],"prefix":"10.1093","volume":"66","author":[{"given":"Yeon Joo","family":"Lee","sequence":"first","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York"},{"name":"Department of Medicine, Weill Cornell Medical College, Cornell University, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Ting","family":"Huang","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Kerpelev","sequence":"additional","affiliation":[{"name":"Information Systems, Memorial Sloan Kettering Cancer Center, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kaltsas","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York"},{"name":"Department of Medicine, Weill Cornell Medical College, Cornell University, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genovefa","family":"Papanicolaou","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York"},{"name":"Department of Medicine, Weill Cornell Medical College, Cornell University, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"key\n\t\t\t\t20180328143130_CIT0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cid\/civ803","article-title":"Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs","volume":"62","author":"Shigayeva","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0002","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1017\/S0950268810000919","article-title":"Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20180328143130_CIT0003","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","article-title":"The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults","volume":"192","author":"Kyaw","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0004","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328143130_CIT0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3201\/eid1901.120741","article-title":"Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales","volume":"19","author":"Ladhani","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2334-8-96","article-title":"Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies","volume":"8","author":"Klemets","year":"2008","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180328143130_CIT0008","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/cid\/cit640","article-title":"Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies","volume":"57","author":"Luj\u00e1n","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0009","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00007890-199403150-00009","article-title":"Polysaccharide conjugate vaccine responses in bone marrow transplant patients","volume":"57","author":"Guinan","year":"1994","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180328143130_CIT0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0609.1993.tb01601.x","article-title":"Lethal infections in patients with hematological malignancies","volume":"51","author":"Salonen","year":"1993","journal-title":"Eur J Haematol"},{"key":"key\n\t\t\t\t20180328143130_CIT0011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0012","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328143130_CIT0013","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cir326","article-title":"Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States","volume":"53","author":"Rosen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0014","author":"Centers for Disease Control and Prevention"},{"key":"key\n\t\t\t\t20180328143130_CIT0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0016","author":"National Cancer Institute; Surveillance, Epidemiology, and End Results Program"},{"key":"key\n\t\t\t\t20180328143130_CIT0017","author":"National Cancer Institute; Surveillance, Epidemiology, and End Results Program"},{"key":"key\n\t\t\t\t20180328143130_CIT0018","author":"Clinical and Laboratory Standards Institute"},{"key":"key\n\t\t\t\t20180328143130_CIT0019","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(05)65585-7","article-title":"Carriage of pneumococci after pneumococcal vaccination","volume":"348","author":"Obaro","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328143130_CIT0021","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1086\/425422","article-title":"Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska","volume":"190","author":"Moore","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0022","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMe068038","article-title":"Pneumococcal vaccine\u2013direct and indirect (\u201cherd\u201d) effects","volume":"354","author":"Musher","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328143130_CIT0023","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.vaccine.2009.05.037","article-title":"Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France","volume":"28","author":"Cohen","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328143130_CIT0024","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw194.79","article-title":"Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease among Children and Adults in the U.S","volume-title":"IDWeek 2016","author":"Pilishvili","year":"2016"},{"key":"key\n\t\t\t\t20180328143130_CIT0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/14760584.2014.859990","article-title":"Pneumococcal immunization in immunocompromised hosts: where do we stand","volume":"13","author":"Cordonnier","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180328143130_CIT0026","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/23744235.2015.1115894","article-title":"Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland","volume":"48","author":"Lindstr\u00f6m","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"key\n\t\t\t\t20180328143130_CIT0027","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jinf.2015.07.004","article-title":"Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed","volume":"71","author":"Sangil","year":"2015","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180328143130_CIT0028","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv133.1442","article-title":"Impact of PCV7 and PCV13 on the serotype distribution of invasive pneumococcal disease in adults in Kansas City","volume-title":"IDWeek 2015","author":"Merino","year":"2015"},{"key":"key\n\t\t\t\t20180328143130_CIT0029","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.amepre.2006.06.007","article-title":"Adults with invasive pneumococcal disease: missed opportunities for vaccination","volume":"31","author":"Kyaw","year":"2006","journal-title":"Am J Prev Med"},{"key":"key\n\t\t\t\t20180328143130_CIT0030","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20180328143130_CIT0031","doi-asserted-by":"crossref","first-page":"e2016044","DOI":"10.4084\/mjhid.2016.044","article-title":"Influenza and pneumococcal vaccination in hematological malignancies: a systematic review of efficacy, effectiveness, and safety","volume":"8","author":"La Torre","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"key\n\t\t\t\t20180328143130_CIT0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1385\/MO:19:2:71","article-title":"Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae","volume":"19","author":"Nord\u00f8y","year":"2002","journal-title":"Med Oncol"},{"key":"key\n\t\t\t\t20180328143130_CIT0033","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/adc.2010.198416","article-title":"Humoral response to conjugate pneumococcal vaccine in paediatric oncology patients","volume":"97","author":"Cheng","year":"2012","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t20180328143130_CIT0034","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0609.1989.tb01250.x","article-title":"Antibody response to pneumococcal vaccine in patients with early stage Hodgkin\u2019s disease","volume":"43","author":"Frederiksen","year":"1989","journal-title":"Eur J Haematol"},{"key":"key\n\t\t\t\t20180328143130_CIT0035","doi-asserted-by":"crossref","first-page":"e114966","DOI":"10.1371\/journal.pone.0114966","article-title":"Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients\u2014preliminary report","volume":"9","author":"Pasiarski","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328143130_CIT0036","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.bbmt.2015.08.010","article-title":"Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies","volume":"21","author":"Shah","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20180328143130_CIT0037","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bbmt.2008.06.012","article-title":"Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)","volume":"14","author":"Pao","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t20180328143130_CIT0038","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children\u2014use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20180328143130_CIT0039","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/66\/2\/244\/24265746\/cix739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T06:23:22Z","timestamp":1569997402000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/66\/2\/244\/4084327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,8,17]]},"published-print":{"date-parts":[[2018,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix739","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1,15]]},"published":{"date-parts":[[2017,8,17]]}}}